Similar articles for PMID: 29963937

Year	Number of Results
1995	2
1996	2
1997	3
1998	3
2000	2
2001	1
2002	2
2003	1
2004	2
2005	3
2006	2
2007	5
2008	3
2009	7
2010	1
2011	4
2012	4
2013	4
2014	10
2015	7
2016	9
2017	8
2018	13
2019	7
2020	7
2021	4
2022	5
2024	0

1

Interaction between CYP2D6 inhibitor antidepressants and codeine: is this relevant?

Cazet L, Bulteau S, Evin A, Spiers A, Caillet P, Kuhn E, Pivette J, Chaslerie A, Jolliet P, Victorri-Vigneau C. Cazet L, et al. Expert Opin Drug Metab Toxicol. 2018 Aug;14(8):879-886. doi: 10.1080/17425255.2018.1496236. Epub 2018 Jul 12. Expert Opin Drug Metab Toxicol. 2018. PMID: 29963937 Review.

2

Cytochrome P450 2D6 and treatment of codeine dependence.

Romach MK, Otton SV, Somer G, Tyndale RF, Sellers EM. Romach MK, et al. J Clin Psychopharmacol. 2000 Feb;20(1):43-5. doi: 10.1097/00004714-200002000-00008. J Clin Psychopharmacol. 2000. PMID: 10653207

3

The pharmacogenetics of codeine hypoalgesia.

Sindrup SH, Brøsen K. Sindrup SH, et al. Pharmacogenetics. 1995 Dec;5(6):335-46. doi: 10.1097/00008571-199512000-00001. Pharmacogenetics. 1995. PMID: 8845855 Review.

4

Serotonin and Norepinephrine Reuptake Inhibitors.

Shelton RC. Shelton RC. Handb Exp Pharmacol. 2019;250:145-180. doi: 10.1007/164_2018_164. Handb Exp Pharmacol. 2019. PMID: 30838456

5

SNRIs achieve faster antidepressant effects than SSRIs by elevating the concentrations of dopamine in the forebrain.

Li J, Lu C, Gao Z, Feng Y, Luo H, Lu T, Sun X, Hu J, Luo Y. Li J, et al. Neuropharmacology. 2020 Oct 15;177:108237. doi: 10.1016/j.neuropharm.2020.108237. Epub 2020 Jul 23. Neuropharmacology. 2020. PMID: 32710978

6

Combining Antidepressants with β-Blockers: Evidence of a Clinically Significant CYP2D6 Drug Interaction.

Shin J, Hills NK, Finley PR. Shin J, et al. Pharmacotherapy. 2020 Jun;40(6):507-516. doi: 10.1002/phar.2406. Epub 2020 May 22. Pharmacotherapy. 2020. PMID: 32342526

7

Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression.

Berrocoso E, Mico JA. Berrocoso E, et al. Int J Neuropsychopharmacol. 2009 Sep;12(8):1033-44. doi: 10.1017/S1461145709000236. Epub 2009 Apr 3. Int J Neuropsychopharmacol. 2009. PMID: 19341511 Free article.

8

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype.

Crews KR, Gaedigk A, Dunnenberger HM, Klein TE, Shen DD, Callaghan JT, Kharasch ED, Skaar TC; Clinical Pharmacogenetics Implementation Consortium. Crews KR, et al. Clin Pharmacol Ther. 2012 Feb;91(2):321-6. doi: 10.1038/clpt.2011.287. Epub 2011 Dec 28. Clin Pharmacol Ther. 2012. PMID: 22205192 Free PMC article.

9

Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen.

Binkhorst L, Mathijssen RH, van Herk-Sukel MP, Bannink M, Jager A, Wiemer EA, van Gelder T. Binkhorst L, et al. Breast Cancer Res Treat. 2013 Jun;139(3):923-9. doi: 10.1007/s10549-013-2585-z. Epub 2013 Jun 13. Breast Cancer Res Treat. 2013. PMID: 23760858

10

Treatment of codeine dependence with inhibitors of cytochrome P450 2D6.

Fernandes LC, Kilicarslan T, Kaplan HL, Tyndale RF, Sellers EM, Romach MK. Fernandes LC, et al. J Clin Psychopharmacol. 2002 Jun;22(3):326-9. doi: 10.1097/00004714-200206000-00014. J Clin Psychopharmacol. 2002. PMID: 12006904 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

110 results

Results by year